Read the latest news about Healx and our goal to advance treatments for rare diseases.
The start-up company, Healx, founded by Dr Tim Guilliams and based on core research performed in the group of Dr Andreas Bender at the Chemistry Department of Cambridge University, was awarded “Life Science Business of the Year 2015” at the Grand Finale of Cambridge University Entrepreneurs and Carpe Diem Enterprise awards on 15 May. READ … Continued
READ FULL CAMBRIDGE NEWS ARTICLE HERE.
Cambridge startup Healx, which matches safe drugs to rare diseases, is launching a rare disease network to improve dialogue and promote best practice in this specialist field of medical technology. READ FULL BUSINESS WEEKLY ARTICLE HERE.
A Cambridge UK medical technology startup which matches safe drugs to rare diseases is working on a potential cure for a six-year-old American boy who is the first patient ever to be diagnosed with NGLY-1 deficiency and loss of function. READ BUSINESS WEEKLY ARTICLE HERE.